Literature DB >> 11559836

Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression.

L M del Mar Peña1, L A Laimins.   

Abstract

The life cycle of human papillomaviruses (HPVs) is tightly linked to the differentiation status of the host cell. While early genes are expressed during the initial stages of viral infection, late gene expression occurs in the suprabasal layers of the cervical epithelium. Late genes encode E1-E4, a cytosolic protein, and capsid proteins L1 and L2. We have mapped over 30 initiation sites for late transcripts and show that the transcripts initiate in a 200-nucleotide region within the E7 open reading frame. The mechanisms regulating the activation of late gene expression, however, are not yet understood. DNase I hypersensitivity analysis of HPV-31 chromatin in cell lines that maintain viral genomes extrachromosomally indicates that a major shift in nuclease digestion occurs upon differentiation. In undifferentiated cells, hypersensitive regions exist in the upstream regulatory region proximal to the E6 open reading frame. Upon differentiation, a region between nucleotides 659 and 811 in the E7 open reading frame becomes accessible to DNase I. These results indicate that the late transcript initiation region becomes accessible to transcription factor binding upon differentiation. Several complexes mediate chromatin rearrangement, and we tested whether histone acetylation was sufficient for late transcript activation. Treatment with the histone deacetylase inhibitor trichostatin A was found to be insufficient to activate late gene expression in undifferentiated cells. However, it did activate expression of early transcripts. These results suggest that chromatin remodeling around the late promoter occurs upon epithelial differentiation and that mechanisms in addition to histone deacetylation contribute to activation of late gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559836      PMCID: PMC114575          DOI: 10.1128/JVI.75.20.10005-10013.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  In vitro assembly of a positioned nucleosome near the hypersensitive region in simian virus 40 chromatin.

Authors:  J H Powers; M Bina
Journal:  J Mol Biol       Date:  1991-10-05       Impact factor: 5.469

4.  SV40 early-to-late switch involves titration of cellular transcriptional repressors.

Authors:  S R Wiley; R J Kraus; F Zuo; E E Murray; K Loritz; J E Mertz
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

5.  Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells.

Authors:  M Yoshida; Y Hoshikawa; K Koseki; K Mori; T Beppu
Journal:  J Antibiot (Tokyo)       Date:  1990-09       Impact factor: 2.649

Review 6.  The biology of human papillomaviruses: from warts to cancer.

Authors:  L A Laimins
Journal:  Infect Agents Dis       Date:  1993-04

7.  Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation.

Authors:  G D Higgins; D M Uzelin; G E Phillips; P McEvoy; R Marin; C J Burrell
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

8.  Transient replication of human papillomavirus DNAs.

Authors:  A M Del Vecchio; H Romanczuk; P M Howley; C C Baker
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.

Authors:  M G Frattini; L A Laimins
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

10.  Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation.

Authors:  M A Bedell; J B Hudson; T R Golub; M E Turyk; M Hosken; G D Wilbanks; L A Laimins
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more
  33 in total

1.  Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding.

Authors:  Tonia R Wooldridge; Laimonis A Laimins
Journal:  Virology       Date:  2008-01-31       Impact factor: 3.616

2.  BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.

Authors:  Mary A Morse; Karla K Balogh; Sarah A Brendle; Colin A Campbell; Mao X Chen; Rebecca C Furze; Isobel L Harada; Ian D Holyer; Umesh Kumar; Kevin Lee; Rab K Prinjha; Martin Rüdiger; Jonathan T Seal; Simon Taylor; Jason Witherington; Neil D Christensen
Journal:  Antiviral Res       Date:  2018-04-11       Impact factor: 5.970

3.  Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.

Authors:  William K Songock; Matthew L Scott; Jason M Bodily
Journal:  Virology       Date:  2017-04-24       Impact factor: 3.616

4.  Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.

Authors:  Vignesh Gunasekharan; Guylaine Haché; Laimonis Laimins
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

Authors:  Elizabeth Gray; Mark R Pett; Dawn Ward; David M Winder; Margaret A Stanley; Ian Roberts; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

6.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules.

Authors:  Ingo Ammermann; Markus Bruckner; Frank Matthes; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

Review 8.  Human papillomaviruses and the interferon response.

Authors:  Melanie Beglin; Marta Melar-New; Laimonis Laimins
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

9.  Clonal selection for transcriptionally active viral oncogenes during progression to cancer.

Authors:  Brian A Van Tine; John C Kappes; N Sanjib Banerjee; Judith Knops; Lilin Lai; Renske D M Steenbergen; Chris L J M Meijer; Peter J F Snijders; Pamela Chatis; Thomas R Broker; Phillip T Moen; Louise T Chow
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 10.  Papillomavirus interaction with cellular chromatin.

Authors:  Jianxin You
Journal:  Biochim Biophys Acta       Date:  2009-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.